ES8603957A1 - Procedimiento para obtener una proteina heterologa para levadura - Google Patents
Procedimiento para obtener una proteina heterologa para levaduraInfo
- Publication number
- ES8603957A1 ES8603957A1 ES531898A ES531898A ES8603957A1 ES 8603957 A1 ES8603957 A1 ES 8603957A1 ES 531898 A ES531898 A ES 531898A ES 531898 A ES531898 A ES 531898A ES 8603957 A1 ES8603957 A1 ES 8603957A1
- Authority
- ES
- Spain
- Prior art keywords
- yeast
- therefor
- heterologous protein
- expressing heterologous
- expression vehicles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6478—Aspartic endopeptidases (3.4.23)
- C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE UNA PROTEINA HETEROLOGA A UN CULTIVO HOSPEDANTE DE LEVADURA. COMPRENDE LA TRANSFORMACION DE UN ORGANISMO HOSPEDANTE DE LEVADURA CON UN VEHICULO DE EXPANSION DE LEVADURA QUE CONTIENE LA SECUENCIA DE ACIDO DESOXIRRIBONUCLEICO (ADN) QUE CODIFICA UNA PROTEINA HETEROLOGA PARA EL ORGANISMO DE LEVADURA, BAJO CONTROL DE UNA SECUENCIA DE ADN QUE CODIFICA EL PROMOTOR PARA FACTOR ALFA DE LEVADURA Y EL PREPROPEPTIDO DEL FACTOR ALFA DE LA MISMA; SEGUIDA DEL CULTIVO DEL ORGANISMO TRANSFORMADO EN UN MEDIO DE CULTIVO ADECUADO; Y RECUPERACION DE LA PROTEINA, SELECCIONADA ENTRE INTERFERON HUMANO O BOVINO, ACTIVADOR DE PLASMINOGENO DEL TIPO DE TEJIDO HUMANO, RENINA Y FACTOR DE CRECIMIENTO DE INSULINA. TIENE APLICACIONES PARA LA PRODUCCION DE PRODUCTOS PROTEINICOS EMPLEADOS EN DIVERSOS TRATAMIENTOS PROFILACTICOS Y TERAPEUTICOS.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48832383A | 1983-04-25 | 1983-04-25 | |
US50135283A | 1983-06-06 | 1983-06-06 | |
US50609883A | 1983-06-20 | 1983-06-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES531898A0 ES531898A0 (es) | 1986-01-16 |
ES8603957A1 true ES8603957A1 (es) | 1986-01-16 |
Family
ID=27413799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES531898A Expired ES8603957A1 (es) | 1983-04-25 | 1984-04-25 | Procedimiento para obtener una proteina heterologa para levadura |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0123544A3 (es) |
KR (1) | KR840008695A (es) |
DK (1) | DK204784A (es) |
ES (1) | ES8603957A1 (es) |
IL (1) | IL71621A0 (es) |
NZ (1) | NZ207926A (es) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK172738B1 (da) * | 1983-04-07 | 1999-06-21 | Chiron Corp | Fremgangsmåde til at udtrykke modent insulin og DNA-struktur til anvendelse ved fremgangsmåden |
DE3486216T2 (de) * | 1983-04-25 | 1994-02-17 | Chiron Corp | Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren. |
IL71991A (en) * | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
US4870008A (en) * | 1983-08-12 | 1989-09-26 | Chiron Corporation | Secretory expression in eukaryotes |
US4925791A (en) * | 1984-07-20 | 1990-05-15 | Celltech Limited | Eucaryotic expression vectors |
GB2177095B (en) * | 1984-07-20 | 1988-05-25 | Celltech Ltd | Eucaryotic expression vectors |
DE3587205T2 (de) * | 1984-07-30 | 1993-08-26 | Wakunaga Seiyaku Kk | Verfahren zur herstellung eines proteins und dafuer zu verwendender vektor, rekombinante dns und transformierte zelle. |
US5498600A (en) * | 1984-10-12 | 1996-03-12 | Zymogenetics, Inc. | Biologically active mosaic proteins |
US5187263A (en) * | 1984-10-12 | 1993-02-16 | Zymogenetics, Inc. | Expression of biologically active PDGE analogs in eucaryotic cells |
EP0487116B1 (en) * | 1984-10-12 | 1999-12-29 | ZymoGenetics, Inc. | Biologically active PDGF analogs in eucaryotic cells |
US5045633A (en) * | 1985-02-25 | 1991-09-03 | Zymogenetics, Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
US5821079A (en) * | 1985-05-02 | 1998-10-13 | Transgene S.A. | Vectors for the expression and secretion of hirudin by transformed yeasts |
FR2593518B1 (fr) * | 1985-05-02 | 1989-09-08 | Transgene Sa | Vecteurs d'expression et de secretion de l'hirudine par les levures transformees |
GB8521496D0 (en) * | 1985-08-29 | 1985-10-02 | Ciba Geigy Ag | Repressible yeast promoters |
US4937189A (en) * | 1985-10-18 | 1990-06-26 | Pfizer Inc. | Expression and secretion of heterologous proteins by Yarrowia lipolytica transformants |
DE3540075A1 (de) * | 1985-11-12 | 1987-05-14 | Boehringer Ingelheim Int | Human-lysozym |
US5024941A (en) * | 1985-12-18 | 1991-06-18 | Biotechnica International, Inc. | Expression and secretion vector for yeast containing a glucoamylase signal sequence |
ZA872534B (en) * | 1986-05-08 | 1987-11-25 | Phillips Petroleum Co | Yeast production of streptokinase |
US5002876A (en) * | 1986-09-22 | 1991-03-26 | Phillips Petroleum Company | Yeast production of human tumor necrosis factor |
US5013652A (en) * | 1986-10-14 | 1991-05-07 | Genex Corporation | Composite yeast vectors |
US5420242A (en) * | 1986-10-22 | 1995-05-30 | Kaare M. Gautvik | Production of human parathyroid hormone from microorganisms |
US5010010A (en) * | 1986-10-22 | 1991-04-23 | Selmer-Sande, A.S. | Production of human parathyroid hormone from microorganisms |
AU627147B2 (en) | 1986-10-22 | 1992-08-20 | Peter Alestrom | Production of human parathyroid hormone from microorganisms |
MY103358A (en) * | 1987-04-15 | 1993-06-30 | Novartis Ag | Process for the production of protiens. |
US5266474A (en) * | 1987-06-24 | 1993-11-30 | Genentech, Inc. | Balanced inducible transcription system |
US5063154A (en) * | 1987-06-24 | 1991-11-05 | Whitehead Institute For Biomedical Research | Pheromone - inducible yeast promoter |
WO1988010308A1 (en) * | 1987-06-24 | 1988-12-29 | Whitehead Institute For Biomedical Research | Pheromone-inducible yeast promoter |
US5010182A (en) * | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
US5879907A (en) * | 1987-09-14 | 1999-03-09 | Skandigen Ab | Artificial gene coding for authentic human serum albumin, use thereof and method |
SE459586B (sv) * | 1987-09-14 | 1989-07-17 | Mta Szegedi Biolog Koezponti | Strukturgen som kodar foer autentiskt humant serum albumin och foerfarande foer dess framstaellning |
ZA889415B (en) * | 1987-12-18 | 1989-09-27 | Chiron Corp | Compositions and method for recombinant production of crotalidus venum fibrolase |
CA1340772C (en) * | 1987-12-30 | 1999-09-28 | Patricia Tekamp-Olson | Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences |
HU213571B (en) * | 1988-07-23 | 1997-08-28 | Delta Biotechnology Ltd | Process for producing peptides and dna sequences |
JPH0671434B2 (ja) * | 1989-09-18 | 1994-09-14 | 株式会社ミドリ十字 | ヒト血清アルブミンの製造方法 |
DK0548165T3 (da) | 1990-09-13 | 2001-07-16 | Univ Duke | Ekspression af G-proteinkoblede receptorer i gær |
US5378823A (en) * | 1990-11-29 | 1995-01-03 | Institut National De La Recherche Agronomique-I.N.R.A. | Nucleic acids encoding type I interferon variants |
FR2669931B1 (fr) * | 1990-11-29 | 1995-03-31 | Transgene | Nouveaux variants derives des interferons-alpha et leur procede de production. |
JPH0671432B2 (ja) * | 1991-03-20 | 1994-09-14 | 株式会社ミドリ十字 | ヒト血清アルブミンの製造方法 |
FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
US5538863A (en) * | 1993-07-01 | 1996-07-23 | Immunex Corporation | Expression system comprising mutant yeast strain and expression vector encoding synthetic signal peptide |
JPH07308199A (ja) | 1994-05-18 | 1995-11-28 | Green Cross Corp:The | ヒト血清アルブミンの製造方法 |
US6500645B1 (en) | 1994-06-17 | 2002-12-31 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
EP1683860B1 (en) | 1995-03-17 | 2013-10-23 | Novozymes A/S | Novel endoglucanases |
GB9526733D0 (en) | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
EP1975177B1 (en) | 1996-03-01 | 2011-04-13 | Novo Nordisk A/S | An appetite-suppressing peptide, its compositions and use |
CA2266543C (en) * | 1996-09-24 | 2003-12-09 | Cadus Pharmaceutical Corporation | Methods and compositions for identifying receptor effectors |
US6265186B1 (en) | 1997-04-11 | 2001-07-24 | Dsm N.V. | Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal RNA encoding domain, particularly with Kluyveromyces |
SE9702401D0 (sv) | 1997-06-19 | 1997-06-19 | Astra Ab | Pharmaceutical use |
US6946134B1 (en) | 2000-04-12 | 2005-09-20 | Human Genome Sciences, Inc. | Albumin fusion proteins |
CA2405709A1 (en) | 2000-04-12 | 2001-10-25 | Human Genome Sciences, Inc. | Albumin fusion proteins |
EP1373493B1 (en) | 2001-03-22 | 2013-07-31 | Novo Nordisk Health Care AG | Coagulation factor vii derivative |
US7507413B2 (en) | 2001-04-12 | 2009-03-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
ATE532858T1 (de) | 2001-09-27 | 2011-11-15 | Novo Nordisk Healthcare Ag | Menschliche gerinnungsfaktor-vii-polypeptide |
CA2471363C (en) | 2001-12-21 | 2014-02-11 | Human Genome Sciences, Inc. | Albumin fusion proteins |
GB0217033D0 (en) | 2002-07-23 | 2002-08-28 | Delta Biotechnology Ltd | Gene and polypeptide sequences |
WO2004024885A2 (en) | 2002-09-13 | 2004-03-25 | Cornell Research Foundation, Inc. | Using mutations to improve aspergillus phytases |
ES2381110T3 (es) | 2003-09-09 | 2012-05-23 | Novo Nordisk Health Care Ag | Polipéptidos de factor VII de coagulación |
BRPI0609079A2 (pt) | 2005-04-18 | 2010-11-16 | Novo Nordisk As | peptìdeo, composição farmacêutica, método para o tratamento de cáncer, uso de um peptìdeo construto de ácido nucleico, vetor, hospedeiro, e, anticorpo |
JP5690047B2 (ja) | 2005-09-14 | 2015-03-25 | ノボ ノルディスク ヘルス ケア アーゲー | ヒト凝固第vii因子ポリペプチド |
CN106008699A (zh) | 2006-09-08 | 2016-10-12 | Ambrx公司 | 经修饰的人类血浆多肽或Fc骨架和其用途 |
AU2009247173B2 (en) | 2008-05-15 | 2014-04-17 | R-Tech Ueno, Ltd. | Pharmaceutical composition for treatment of dry eye and/or corneal/conjunctival disorders |
US20120107267A1 (en) | 2009-03-11 | 2012-05-03 | Novo Nordisk A/S | Interleukin-21 variants having antagonistic binding to the il-21 receptor |
KR102184713B1 (ko) | 2009-07-17 | 2020-12-01 | 오메로스 코포레이션 | 보체 활성화의 억제제로서의 masp 이소형 |
US9096843B2 (en) | 2009-12-01 | 2015-08-04 | Novo Nordisk A/S | Peptidyl α-hydroxyglycine α-amidating lyases |
AU2011222883B2 (en) | 2010-03-05 | 2016-05-26 | Omeros Corporation | Chimeric inhibitor molecules of complement activation |
JP6517018B2 (ja) | 2012-02-09 | 2019-05-22 | ヴァー2・ファーマシューティカルズ・アンパルトセルスカブVAR2 Pharmaceuticals ApS | コンドロイチン硫酸グリカンのターゲティング |
EP2906693A1 (en) | 2012-10-15 | 2015-08-19 | Novo Nordisk Health Care AG | Coagulation factor vii polypeptides |
CN107250163A (zh) | 2015-02-06 | 2017-10-13 | 嘉吉公司 | 修饰的葡糖淀粉酶和具有增强的生物产物产生的酵母菌株 |
CN107429220A (zh) | 2015-03-27 | 2017-12-01 | 嘉吉公司 | 经葡糖淀粉酶修饰的酵母菌株和用于产生生物产物的方法 |
EA037848B1 (ru) | 2016-07-14 | 2021-05-27 | Общество С Ограниченной Ответственностью "Биохимический Агент" | Гибридный белок, полинуклеотид, генетическая конструкция, продуцент, препарат для регенерации хряща (варианты) |
EP3494129A1 (en) | 2016-08-05 | 2019-06-12 | Cargill, Incorporated | Leader-modified glucoamylase polypeptides and engineered yeast strains having enhanced bioproduct production |
CN112789504A (zh) | 2018-07-13 | 2021-05-11 | 瓦克特诊断有限责任公司 | 使用重组疟疾蛋白var2csa分离胎儿来源的循环细胞 |
WO2022049409A1 (en) | 2020-09-02 | 2022-03-10 | Sia Terragen | Express diagnosticum for sars-cov-2 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3382547D1 (de) * | 1983-01-12 | 1992-05-27 | Chiron Corp | Sekretorische expression in eukaryoten. |
DK172738B1 (da) * | 1983-04-07 | 1999-06-21 | Chiron Corp | Fremgangsmåde til at udtrykke modent insulin og DNA-struktur til anvendelse ved fremgangsmåden |
JPS60501140A (ja) * | 1983-04-22 | 1985-07-25 | アムジエン | 酵母による外因性ポリペプチドの分泌 |
DE3486216T2 (de) * | 1983-04-25 | 1994-02-17 | Chiron Corp | Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren. |
US4588684A (en) * | 1983-04-26 | 1986-05-13 | Chiron Corporation | a-Factor and its processing signals |
JPS59227899A (ja) * | 1983-05-25 | 1984-12-21 | チロン・コ−ポレイシヨン | 成長ホルモン放出因子の製造方法 |
IL71991A (en) * | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
JPS61500586A (ja) * | 1983-11-14 | 1986-04-03 | チロン コ−ポレイシヨン | インタ−ロイキン−2産生のための方法及び組成物 |
DE3588006T2 (de) * | 1984-04-19 | 1995-08-10 | Scios Nova Inc | Atrielle natriumuretische/gefässerweiterende polypeptide. |
-
1984
- 1984-04-19 NZ NZ207926A patent/NZ207926A/en unknown
- 1984-04-24 DK DK204784A patent/DK204784A/da not_active Application Discontinuation
- 1984-04-24 KR KR1019840002188A patent/KR840008695A/ko not_active IP Right Cessation
- 1984-04-24 EP EP84302723A patent/EP0123544A3/en not_active Withdrawn
- 1984-04-24 IL IL71621A patent/IL71621A0/xx unknown
- 1984-04-25 ES ES531898A patent/ES8603957A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP0123544A2 (en) | 1984-10-31 |
EP0123544A3 (en) | 1986-07-16 |
KR840008695A (ko) | 1984-12-17 |
ES531898A0 (es) | 1986-01-16 |
IL71621A0 (en) | 1984-07-31 |
DK204784A (da) | 1984-10-26 |
DK204784D0 (da) | 1984-04-24 |
NZ207926A (en) | 1988-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8603957A1 (es) | Procedimiento para obtener una proteina heterologa para levadura | |
EP0120551A3 (en) | Yeast expression systems with vectors having gapdh or pyk promoters, and synthesis of foreign proteins | |
IL87255A (en) | Dna constructs containing a kluyveromycesalpha- factorleader sequence for directingsecretion of heterologouspolypeptides | |
IE883612L (en) | Vectors and compounds for direct expression of activated human protein c | |
IL68366A (en) | Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture | |
ES8609467A1 (es) | Procedimiento para preparar un polipetido de interes en una cepa de bacilus industrial | |
IE930804L (en) | Regulatory region for heterologous gene expression in yeast | |
AU576757B2 (en) | Production of human insulin-like growth factor through biogenetic techniques | |
ATE46536T1 (de) | Verfahren zur herstellung von reifen proteinen in wirtzellen von wirbeltieren. | |
IE820069L (en) | Recombinant dna encoding a polypeptide | |
JPS56154999A (en) | Synthesis of selective aged protein or polypeptide in bacteria matrix | |
EP0260148A3 (en) | Improved recombinant expression method, vector and transformed cells | |
ES8602138A1 (es) | Metodo de controlar la expresion de un gen que codifica una proteinaheterologa deseada. | |
ES8703930A1 (es) | Procedimiento de preparar hirudina y analogos a partir de levadura | |
AU615413B2 (en) | Production of thrombin inhibitors | |
AU574415B2 (en) | Fermentation processes and their products | |
IE873300L (en) | Expression vectors | |
MY103364A (en) | Synthetic porcine growth hormone | |
EP0171000A3 (en) | Process for producing heterologous matured protein or peptide | |
IE881779L (en) | Dna fragments, containing a lactic acid bacterium-specific¹regulator region for the expression of genes coding for¹normally heterologous proteins, recombinant plasmids based¹on such dna fragments, lactic acid bacteria which contain¹these recombinant plasmids and the heterologous proteins and¹products prepared with the aid of the above microorganisms | |
KR870006185A (ko) | 트롬빈 억제제의 제조방법 | |
KR840004163A (ko) | 효모에 의한 이종성 단백질의 표현, 처리 및 분비방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 20051102 |